Rocky Mountain Spotted Fever Workup
- Author: Burke A Cunha, MD; Chief Editor: Michael Stuart Bronze, MD more...
Approach Considerations
Rocky Mountain spotted fever (RMSF) diagnosis relies on clinical (fever, rash, myalgia) and epidemiologic (tick exposure) criteria. However, a clinical diagnosis of RMSF is difficult to establish, and laboratory findings are nonspecific. Immunologic methods for detection of rickettsiae are unavailable in most clinics. Even so, basic laboratory tests should be obtained, including the following: complete blood count (CBC), electrolytes, renal function tests, liver function tests, and coagulation panel.[15]
After exposure to vector ticks, patients who develop fever, petechial rash, and vomiting require antibiotic therapy. Antibiotic therapy should be initiated before laboratory confirmation is available.
Laboratory findings can include the following:
- White blood cell (WBC) count - Leukopenia is present initially, then mild leukocytosis; patients usually have a normal WBC count
- Platelets - Thrombocytopenia (< 150,000 cells/µL) occurs in 32-52% of patients; abnormalities indicative of DIC are present in severely ill patients
- Hemoglobin and hematocrit - Anemia is present in 5-24% of patients
- Aminotransferase levels - Mildly elevated in 36-62% of patients
- Hyponatremia - Present in 19-56% of cases
- Bilirubin levels – Increased in 8-9% of patients.
- Mild cerebrospinal fluid pleocytosis with monocyte predominance
- Azotemia - Develops in 12-14% of cases
- Prothrombin time and activated partial thromboplastin time - May be elevated
Anemia, an increased blood urea nitrogen (BUN) level, or abnormal liver function test results are found in 30% of patients. Late findings associated with advanced disease include signs of multiorgan failure, such as elevated BUN, creatinine, and creatinine kinase levels.
Serology
Diagnosis is confirmed based on indirect immunofluorescent antibody (IFA) test results, latex agglutination, or enzyme immunoassay. Serology specific for R rickettsii infection develops within 6-8 weeks. Serologic test results are negative prior to convalescence.
Blood culture
Isolation of R rickettsii from the blood is possible, but few laboratories perform this isolation because of biohazard concerns. This is an insensitive test because most Rickettsia is found in the vascular endothelial cells, not in the bloodstream.
Imaging studies
Obtain a chest radiograph in patients who appear significantly ill or have abnormal lung findings on physical examination. Chest radiographs that show an early pulmonary infiltrate should prompt consideration of a different diagnosis.
Computed tomography (CT) scanning or magnetic resonance imaging (MRI) are indicated for altered mental status or neurologic deficits and may reveal infarction, edema, and meningeal enhancement.
Lumbar puncture
Lumbar puncture usually is performed as part of the workup for suspected meningitis. Pleocytosis is found in 34-38% of cases. Usually 10-100 cells/µL with either lymphocytic or polymorphonuclear cell predominance are found. Increased protein is found in 30-35% of cases; the glucose level usually is normal.
Other tests
The Weil-Felix test is used to detect cross-reacting antibodies against Proteus vulgaris antigens OX-2 and OX-19. This test lacks sensitivity and specificity, and better tests are now available. If the Proteus titer is greater than or equal to 1:320 or if a 4-fold or greater rise to either Proteus OX-19 or OX-2 antigens is observed, an RMSF case that is clinically compatible is considered probable.
Electrocardiography may be used to indicate whether myocardial or conduction abnormalities are present.
Skin Biopsy
Direct immunofluorescent microscopy, if available, may be used for rapid histologic diagnosis of Rocky Mountain spotted fever (RMSF). Immunofluorescent or immunoperoxidase staining of R rickettsii in a biopsy skin or organ specimen is sensitive (73%) and specific (100%).[16] However, because direct immunofluorescence has a 30% false-negative rate, patients should be treated even if the test is negative and the suspicion is high.
Antibodies to specific rickettsial antigens are detected by indirect immunofluorescence (most specific), latex agglutination, and enzyme immunoassay. The diagnostic titer is 1:64 for indirect immunofluorescence and latex agglutination.
Amplification of R rickettsii deoxyribonucleic acid (DNA) with polymerase chain reaction (PCR) assay has not been proven to be a sensitive diagnostic method except for later in the disease course, particularly in fatal cases. It has been successful when applied to biopsy skin samples during rickettsioses and also when applied to ticks. According to Walker and Raoult in 2000, the primers used amplify genes of the 17-kD protein citrate synthetase and rickettsial OmpA and allow the identification of any rickettsial organism.
Sexton DJ, Corey GR. Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin Infect Dis. Sep 1992;15(3):439-48. [Medline].
Salgo MP, Telzak EE, Currie B, et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med. May 26 1988;318(21):1345-8. [Medline].
Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg. Jul 2010;83(1):174-82. [Medline]. [Full Text].
Stromdahl EY, Jiang J, Vince M, Richards AL. Infrequency of Rickettsia rickettsii in Dermacentor variabilis removed from humans, with comments on the role of other human-biting ticks associated with spotted fever group Rickettsiae in the United States. Vector Borne Zoonotic Dis. Jul 2011;11(7):969-77. [Medline].
Marshall GS, Stout GG, Jacobs RF, et al. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med. May 2003;157(5):443-8. [Medline].
Zavala-Castro JE, Dzul-Rosado KR, León JJ, Walker DH, Zavala-Velázquez JE. An increase in human cases of spotted fever rickettsiosis in Yucatan, Mexico, involving children. Am J Trop Med Hyg. Dec 2008;79(6):907-10. [Medline].
Demma LJ, Holman RC, Mikosz CA, et al. Rocky mountain spotted fever hospitalizations among American Indians. Am J Trop Med Hyg. Sep 2006;75(3):537-41. [Medline].
Holman RC, McQuiston JH, Haberling DL, Cheek JE. Increasing incidence of Rocky Mountain spotted fever among the American Indian population in the United States. Am J Trop Med Hyg. Apr 2009;80(4):601-5. [Medline].
Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. May 1995;20(5):1118-21. [Medline].
Archibald LK, Sexton DJ. Long-term sequelae of Rocky Mountain spotted fever. Clin Infect Dis. May 1995;20(5):1122-5. [Medline].
Chen LF, Sexton DJ. What's new in Rocky Mountain spotted fever?. Infect Dis Clin North Am. Sep 2008;22(3):415-32, vii-viii. [Medline].
Sexton DJ, Gallis HA, McRae JR, Cate TR. Letter: Possible needle-associated Rocky Mountain spotted fever. N Engl J Med. Mar 20 1975;292(12):645. [Medline].
Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. Feb 2007;150(2):180-4, 184.e1. [Medline].
Byrd RP Jr, Vasquez J, Roy TM. Respiratory manifestations of tick-borne diseases in the Southeastern United States. South Med J. Jan 1997;90(1):1-4. [Medline].
Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. Mar 31 2006;55:1-27. [Medline].
Procop GW, Burchette JL Jr, Howell DN, Sexton DJ. Immunoperoxidase and immunofluorescent staining of Rickettsia rickettsii in skin biopsies. A comparative study. Arch Pathol Lab Med. Aug 1997;121(8):894-9. [Medline].
Markley KC, Levine AB, Chan Y. Rocky Mountain spotted fever in pregnancy. Obstet Gynecol. May 1998;91(5 Pt 2):860. [Medline].
Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy. J Infect Dis. Dec 1 2001;184(11):1437-44. [Medline].
Minniear TD, Buckingham SC. Managing Rocky Mountain spotted fever. Expert Rev Anti Infect Ther. Nov 2009;7(9):1131-7. [Medline].
Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J. May 1998;17(5):429-31. [Medline].

